Skip to main content
. 2021 May 23;22(11):5493. doi: 10.3390/ijms22115493

Figure 3.

Figure 3

Austalide K suppressed NFATc1 in RANKL-treated osteoclasts. (A) The mRNA expression levels of NFATc1, TRAP, DC-STAMP, and CTSK were detected using qRT-PCR at 3 days after RANKL treatment; (B) The expression level of NFATc1 was measured using Western blot analysis. * p < 0.05; ** p < 0.01; *** p < 0.001.